"We make choices we think are going to save us": Debate and stance identification for online breast cancer CAM discussions.
"We make choices we think are going to save us": Debate and stance identification for online breast cancer CAM discussions.
复制标题
“我们做出我们认为能够拯救我们的选择”:在线乳腺癌 CAM 讨论的辩论和立场识别。
DOI:
10.1145/3041021.3055134
复制
发表时间:
2017
期刊:
影响因子:
--
通讯作者:
Elhadad,Noémie
中科院分区:
文献类型:
--
作者:
Zhang,Shaodian;Qiu,Lin;Chen,Frank;Zhang,Weinan;Yu,Yong;Elhadad,Noémie
Patients discuss complementary and alternative medicine (CAM) in online health communities. Sometimes, patients' conflicting opinions toward CAM-related issues trigger debates in the community. The objectives of this paper are to identify such debates, identify controversial CAM therapies in a popular online breast cancer community, as well as patients' stances towards them. To scale our analysis, we trained a set of classifiers. We first constructed a supervised classifier based on a long short-term memory neural network (LSTM) stacked over a convolutional neural network (CNN) to detect automatically CAM-related debates from a popular breast cancer forum. Members' stances in these debates were also identified by a CNN-based classifier. Finally, posts automatically flagged as debates by the classifier were analyzed to explore which specific CAM therapies trigger debates more often than others. Our methods are able to detect CAM debates with F score of 77%, and identify stances with F score of 70%. The debate classifier identified about 1/6 of all CAM-related posts as debate. About 60% of CAM-related debate posts represent the supportive stance toward CAM usage. Qualitative analysis shows that some specific therapies, such as Gerson therapy and usage of laetrile, trigger debates frequently among members of the breast cancer community. This study demonstrates that neural networks can effectively locate debates on usage and effectiveness of controversial CAM therapies, and can help make sense of patients' opinions on such issues under dispute. As to CAM for breast cancer, perceptions of their effectiveness vary among patients. Many of the specific therapies trigger debates frequently and are worth more exploration in future work.